Brigit Biofarmaka Teknologi Tbk. vs Selaras Citra Nusantara Perkasa Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume), while Selaras Citra Nusantara Perkasa Tbk. trades at Rp153 (market cap 387.5B, 4.65M 24h volume). The key difference: Selaras Citra Nusantara Perkasa Tbk. is far larger — about 2.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Selaras Citra Nusantara Perkasa Tbk. is more actively traded (4.65M versus 324K). Which is the better fit depends on your goals.
| OBAT | SCNP | |
|---|---|---|
Market Cap | 166.01B | 387.5B |
Volume | 324K | 4.65M |
Lot | 3.24K | 46.54K |
Turnover | 77.68M | 754.13M |
Average Price | 239.75 | 162.04 |
Value | 77.68M | 754.13M |
Indicative Equilibrium Price | 240 | 153 |
Indicative Equilibrium Volume | 1 | 9 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Selaras Citra Nusantara Perkasa (the Company),located in Bogor, was established based on Notarial Deed of Sukawaty Sumadi, SH. No. 12 dated 24 January 2000. The Company’s commercial operations started in 2000.
Read more on SCNP →